News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
575,565 Results
Type
Article (41697)
Company Profile (86)
Press Release (533773)
Multimedia
Podcasts (82)
Webinars (19)
Section
Business (153082)
Career Advice (2461)
Deals (27965)
Drug Delivery (123)
Drug Development (73707)
Employer Resources (142)
FDA (14042)
Job Trends (12344)
News (273891)
Policy (27281)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2578)
Academic (1)
Accelerated approval (47)
Adcomms (33)
Allergies (164)
Alliances (38678)
ALS (208)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (453)
Approvals (14395)
Artificial intelligence (620)
Autoimmune disease (276)
Automation (51)
Bankruptcy (312)
Best Places to Work (10029)
BIOSECURE Act (16)
Biosimilars (201)
Biotechnology (63)
Bladder cancer (195)
Brain cancer (68)
Breast cancer (722)
Cancer (5624)
Cardiovascular disease (477)
Career advice (2092)
Career pathing (42)
CAR-T (312)
CDC (56)
Celiac Disease (1)
Cell therapy (851)
Cervical cancer (39)
Clinical research (64474)
Collaboration (1769)
Company closure (6)
Compensation (737)
Complete response letters (86)
COVID-19 (2625)
CRISPR (97)
C-suite (1168)
Cystic fibrosis (132)
Data (7717)
Decentralized trials (3)
Denatured (13)
Depression (172)
Dermatology (84)
Diabetes (565)
Diagnostics (6285)
Digital health (46)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (274)
Drug pricing (185)
Drug shortages (27)
Duchenne muscular dystrophy (286)
Earnings (59854)
Editorial (64)
Employer branding (19)
Employer resources (134)
Events (80734)
Executive appointments (1091)
FDA (17515)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (33)
Funding (1504)
Gene editing (217)
Generative AI (55)
Gene therapy (723)
GLP-1 (1038)
Government (4451)
Grass and pollen (7)
Guidances (405)
Healthcare (16214)
HIV (78)
Huntington's disease (55)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (308)
Immuno-oncology (89)
Indications (179)
Infectious disease (2952)
Inflammatory bowel disease (207)
Inflation Reduction Act (13)
Influenza (126)
Intellectual property (270)
Interviews (530)
IPO (12679)
IRA (49)
Job creations (2602)
Job search strategy (1678)
JPM (56)
Kidney cancer (21)
Labor market (71)
Layoffs (523)
Leadership (46)
Legal (5795)
Liver cancer (98)
Longevity (26)
Lung cancer (772)
Lymphoma (412)
Machine learning (50)
Management (51)
Manufacturing (895)
MASH (210)
Medical device (11076)
Medtech (11179)
Mergers & acquisitions (16400)
Metabolic disorders (1484)
mRNA (192)
Multiple sclerosis (184)
NASH (24)
Neurodegenerative disease (424)
Neuropsychiatric disorders (112)
Neuroscience (3315)
Neurotech (1)
NextGen: Class of 2026 (5555)
Non-profit (4032)
Now hiring (71)
Obesity (678)
Opinion (294)
Ovarian cancer (221)
Pain (248)
Pancreatic cancer (300)
Parkinson's disease (358)
Partnered (28)
Patents (558)
Patient recruitment (652)
Peanut (55)
People (53181)
Pharmaceutical (20)
Pharmacy benefit managers (19)
Phase 1 (19869)
Phase 2 (28372)
Phase 3 (21583)
Pipeline (8500)
Policy (307)
Postmarket research (2325)
Preclinical (8175)
Press Release (54)
Prostate cancer (293)
Psychedelics (62)
Radiopharmaceuticals (285)
Rare diseases (1059)
Real estate (4187)
Recruiting (60)
Regulatory (22152)
Reports (33)
Research institute (2191)
Resumes & cover letters (359)
Rett syndrome (38)
RNA editing (22)
RSV (78)
Schizophrenia (182)
Series A (254)
Series B (185)
Service/supplier (3)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (44)
Startups (2800)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (76)
The Weekly (67)
Vaccines (1019)
Venture capital (102)
Weight loss (452)
Women's health (102)
Worklife (20)
Date
Today (19)
Last 7 days (461)
Last 30 days (2953)
Last 365 days (26510)
2026 (11527)
2025 (26599)
2024 (30650)
2023 (34199)
2022 (44655)
2021 (47916)
2020 (46467)
2019 (39778)
2018 (30161)
2017 (27087)
2016 (25748)
2015 (30151)
2014 (22572)
2013 (18388)
2012 (19585)
2011 (20609)
2010 (18215)
Location
Africa (738)
Alabama (83)
Alaska (4)
Arizona (247)
Arkansas (12)
Asia (35634)
Australia (7380)
California (11057)
Canada (3450)
China (1269)
Colorado (471)
Connecticut (464)
Delaware (375)
Europe (79962)
Florida (1806)
Georgia (360)
Hawaii (1)
Idaho (53)
Illinois (925)
India (83)
Indiana (526)
Iowa (18)
Japan (504)
Kansas (120)
Kentucky (39)
Louisiana (38)
Maine (60)
Maryland (1402)
Massachusetts (7695)
Michigan (319)
Minnesota (552)
Mississippi (5)
Missouri (133)
Montana (26)
Nebraska (26)
Nevada (130)
New Hampshire (79)
New Jersey (3178)
New Mexico (22)
New York (2983)
North Carolina (1415)
North Dakota (7)
Northern California (5469)
Ohio (328)
Oklahoma (13)
Oregon (30)
Pennsylvania (2304)
Puerto Rico (27)
Rhode Island (39)
South America (999)
South Carolina (79)
South Dakota (2)
Southern California (4488)
Tennessee (179)
Texas (1877)
United States (39712)
Utah (366)
Vermont (1)
Virginia (285)
Washington D.C. (65)
Washington State (928)
West Virginia (4)
Wisconsin (103)
Wyoming (2)
575,565 Results for "csl plasma formerly known as zlb plasma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay
May 11, 2026
·
2 min read
Press Releases
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
March 26, 2026
·
5 min read
Press Releases
Roche receives CE mark for new blood test to detect Alzheimer’s pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
May 12, 2026
·
10 min read
Collaboration
Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
CSL is advancing clazakizumab for the treatment of cardiovascular events in end-stage kidney disease and will retain rights over the asset in this indication. Lilly will explore other conditions.
February 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
AB Science announces the identification of a plasma biomarker that indicates the activity of masitinib in treating ALS
February 25, 2026
·
4 min read
Press Releases
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
February 24, 2026
·
3 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s Disease
March 19, 2026
·
3 min read
Press Releases
Zepto Life Technology Launches Plasma-Based FungiFlex® Mold Panel as CLIA Reference Laboratory Test
January 22, 2026
·
2 min read
Press Releases
Resolve Therapeutics to Present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
November 18, 2025
·
2 min read
1 of 57,557
Next
